Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma - Outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the European group for blood and marrow transplantation

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2465-2472

  Sweetenham, J W ^a   Pearce, R ^a   Taghipour, G ^a   Biaise, D ^a   Gisselbrecht, C ^a   Goldstone, A H ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CANCER REGRESSION; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; WHOLE BODY RADIATION;

EID: 0029761785     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2465     Document Type: Article

References (38)

1. Ziegler JL: Burkitt's lymphoma. N Engl J Med 305:735-745, 1981
2. Bouffet E, Frappaz D, Pinkerton R, et al: Burkitt's lymphoma: A model for clinical oncology. Eur J Cancer 27:504-509, 1991
3. Magrath I: Small non-cleaved cell lymphoma, in Magrath IT (ed): Malignant Lymphomas. London, England, Edward Arnold, 1991, pp 254-278
4. Knowles DM, Chamaluk GA, Subar M, et al: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744-753, 1988
5. Non-Hodgkin's Lymphoma Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
6. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
7. Anderson JR, Wilson JF, Jenkin RDT, et al: Childhood nonHodgkin's lymphoma: The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2L2). N Engl J Med 308:559-565, 1983
8. Bernstein JI, Coleman NC, Strickler JG, et al: Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847-858, 1986
9. Coiffier B, Gisselbrecht C. Herbrecht R, et al: LNH-84 regimen: A mulicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018-1026, 1989
10. Lopez TM, Hagemeister FB, McLaughlin P, et al: Small noncleaved cell lymphoma in adults: Superior results for stages I-III disease. J Clin Oncol 8:615-622, 1990
11. 1. Strauss DJ, Wong GY, Liu J. et al: Small non-cleaved cell lymphoma (undifferentiated Burkitt's type) in American adults: Results with treatment designed for acute lymphoblastic leukemia. Am J Med 90:328-337, 1991
12. Longo DL, Duffey PL, Jaffe ES, et al: Diffuse small noncleaved cell, Burkitt's lymphoma in adults: A high grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 12:2153-2159, 1994
13. McMaster ML, Greer JP, Greco A, et al: Effective treatment of small non-cleaved cell lymphoma with high-intensity, brief duration chemotherapy. J Clin Oncol 9:941-946, 1991
14. Magrath IT, Adde M, Shad A, et al: Results in adults with small non-cleaved cell lymphoma treated with a short duration intensive chemotherapy protocol also used in pediatric patients. Proc Am Soc Clin Oncol 13:371, 1995 (abstr)
15. Philip T, Armitage JO, Spitzer G, et al: High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate or high grade non-Hodgkin's lymphoma. N Engl J Med 316:1493-1498, 1987
16. Gribben JG, Goldstone AH, Linch DC, et al: Effectiveness of high dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who are still responsive to conventional dose therapy. J Clin Oncol 7:1621-1629, 1989
17. Nademanee A, Schmidt GM, O'Donnel MR, et al: High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor risk aggressive lymphoma. Blood 80:1130-1134, 1992
18. Freedman AS, Takvorian T, Neuberg D, et al: Autologous bone marrow transplantation in poor prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: A pilot study. J Clin Oncol 1 1:931-936, 1993
19. Sweetenham JW, Proctor SJ, Biaise D, et al: High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: The EBMT experience. Ann Oncol 5:S155-S159, 1994 (suppl 2)
20. Jost LM, Jacky E, Dommann-Scherrer C, et al: Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Ann Oncol 6:445-451, 1995
21. Carbone PP, Kaplan HS, Musshoff K, et al: Report of the Committee on Hodgkin's Disease Staging. Cancer Res 31:1860-1861, 1971
22. 2 protocol. Cancer 44:1990-1999, 1979
23. Armitage JO, Dick FR, Corder MP, et al: Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide. Adriamycin. vincristine and prednisone (CHOP). Cancer 50:16695-1702, 1982
24. Klimo P, Connors JM: MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 102:596-602, 1985
25. Sweetenham JW, Mead GM, Whitehouse JMA: Intensive weekly combination chemotherapy for patients with intermediate grade and high grade non-Hodgkin's lymphoma. J Clin Oncol 9:2202-2209, 1991
26. Velasquez WS, Cabanillas F, Salvador P, et al: Effective salvage therapy for lymphoma with cisplatin in combination with high dose Ara-C and dexamethasone (DHAP). Blood 71:117-122, 1988
27. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. Am J Stat Assoc 53:457-481, 1979
28. Shipp ME, Yeap BY, Harrington DP, et al: The m-BACOD combination chemotherapy regimen in large cell lymphoma: Analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol 8:84-93, 1990
29. Fisher RI, De Vita VT, Hubbard SM, et al: Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 98:304-309, 1983
30. Connors JM, Klimo P: MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observation. Semin Hematol 25:41-46, 1988 (suppl)
31. Patte C, Leverger G, Rubie H, et al: High survival rate in advanced stage B cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-129, 1991
32. Soussain C, Patte C, Ostronoff M, et al: Small non-cleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85:664-674, 1995
33. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Eng! J Med 329:987-992, 1993
34. Hermans J, Krol ADG, van Groningen KK, et al: International prognostic index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades. Blood 86:1460-1463, 1995
35. Divine M, Lepage E, Briere J, et al: Is the small non-cleavedcell lymphoma histolgic subtype a poor prognostic factor in adult patients? A case-controlled analysis. J Clin Oncol 14:240-248, 1996
36. Philip T, Guglielmi C, Chauvin F, et al: Autologous bone marrow transplantation versus (vs) conventional chemotherapy (DHAP) in relapsed non-Hodgkin's lymphoma (NHL): Final analysis of the PARMA randomized study (216 patients). Proc Am Soc Clin Oncol 14:390, 1995 (abstr)
37. Philip T, Pinkerton R, Hartmann O, et al: The role of massive therapy with autologous bone marrow transplantation in Burkitt's lymphoma. Clin Hematol 15:208-215, 1986
38. Philip T, Hartmann O, Pinkerton R, et al: Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: A report from the Societe Francaise d'Oncologie Pediatrique. Blood 81:2003-2006, 1993